Research Article

You have free access to this content

Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy

  1. Florence Legrand-Abravanel1,*,
  2. Philippe Colson2,
  3. Hélène Leguillou-Guillemette3,
  4. Laurent Alric4,
  5. Isabelle Ravaux5,
  6. Françoise Lunel-Fabiani3,
  7. Magali Bouviers-Alias6,
  8. Pascale Trimoulet7,
  9. Marie Laure Chaix8,
  10. Christophe Hézode9,
  11. Juliette Foucher10,
  12. Hélène Fontaine11,
  13. Anne-Marie Roque-Afonso12,
  14. Michèle Gassin13,
  15. Evelyne Schvoerer14,
  16. Catherine Gaudy15,
  17. Bruno Roche16,
  18. Michel Doffoël17,
  19. Louis D'Alteroche18,
  20. Sophie Vallet19,
  21. Yazid Baazia20,
  22. Bruno Pozzetto21,
  23. Vincent Thibault22,
  24. Jean-Baptiste Nousbaum23,
  25. Dominique Roulot24,
  26. Henry Coppere25,
  27. Thierry Poinard26,
  28. Christopher Payan19,
  29. Jacques Izopet1

Article first published online: 25 OCT 2009

DOI: 10.1002/jmv.21583

Issue

Journal of Medical Virology

Journal of Medical Virology

Volume 81, Issue 12, pages 2029–2035, December 2009

Additional Information

How to Cite

Legrand-Abravanel, F., Colson, P., Leguillou-Guillemette, H., Alric, L., Ravaux, I., Lunel-Fabiani, F., Bouviers-Alias, M., Trimoulet, P., Chaix, M. L., Hézode, C., Foucher, J., Fontaine, H., Roque-Afonso, A.-M., Gassin, M., Schvoerer, E., Gaudy, C., Roche, B., Doffoël, M., D'Alteroche, L., Vallet, S., Baazia, Y., Pozzetto, B., Thibault, V., Nousbaum, J.-B., Roulot, D., Coppere, H., Poinard, T., Payan, C. and Izopet, J. (2009), Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy. J. Med. Virol., 81: 2029–2035. doi: 10.1002/jmv.21583

Author Information

  1. 1

    Laboratoire de virologie, Centre Hospitalier-Universitaire, Toulouse, France

  2. 2

    Laboratoire de virologie, Centre Hospitalier-Universitaire, Marseille, France

  3. 3

    Laboratoire de virologie, Centre Hospitalier-Universitaire, Angers, France

  4. 4

    Médecine interne, Centre Hospitalier-Universitaire, Toulouse, France

  5. 5

    Service de maladie infectieuse Centre Hospitalier-Universitaire, Marseille, France

  6. 6

    Laboratoire de virologie, Centre Hospitalier-Universitaire Mondor, Créteil, France

  7. 7

    Laboratoire de virologie, Centre Hospitalier-Universitaire, Bordeaux, France

  8. 8

    Laboratoire de virologie, Centre Hospitalier-Universitaire Necker, Paris, France

  9. 9

    Service de Gastroentérologie, Centre Hospitalier-Universitaire Mondor, Creteil, France

  10. 10

    Service de Gastroentérologie, Centre Hospitalier-Universitaire Bordeaux, France

  11. 11

    Service d'hépatologie Hôpital Cochin, Paris, France

  12. 12

    Laboratoire de virologie, Centre Hospitalier-Universitaire Paul Brousse, Paris, France

  13. 13

    Laboratoire de virologie, Centre Hospitalier-Universitaire, Nantes, France

  14. 14

    Laboratoire de virologie, Centre Hospitalier-Universitaire, Strasbourg, France

  15. 15

    Laboratoire de virologie, Centre Hospitalier-Universitaire, Tours, France

  16. 16

    Centre hépatobiliaire Centre Hospitalier-Universitaire, Paul-Brousse, Paris, France

  17. 17

    Service de Gastroentérologie Centre Hospitalier-Universitaire, Strasbourg, France

  18. 18

    Service de Gastroentérologie Centre Hospitalier-Universitaire, Tours, France

  19. 19

    Laboratoire de virologie, Centre Hospitalier-Universitaire, Brest, France

  20. 20

    Laboratoire de virologie, Centre Hospitalier-Universitaire Avicenne, Bobigny, France

  21. 21

    Laboratoire de virologie, Centre Hospitalier-Universitaire, Saint-Etienne, France

  22. 22

    Laboratoire de virologie, Centre Hospitalier-Universitaire Pitié-Salpétrière, Paris, France

  23. 23

    Service de Gastroentérologie, Centre Hospitalier-Universitaire, Brest, France

  24. 24

    Service de Gastroentérologie, Centre Hospitalier Jean Verdier, Bondy, France

  25. 25

    Service de Gastroentérologie Centre Hospitalier-Universitaire Saint-Etienne, France

  26. 26

    Service de Gastroentérologie Centre Hospitalier-Universitaire Pitié-Salpétrière, Paris, France

*330 Avenue de Grande Bretagne, TSA 40031, Toulouse 31059, France.

Publication History

  1. Issue published online: 25 OCT 2009
  2. Article first published online: 25 OCT 2009
  3. Manuscript Accepted: 26 MAY 2009

Funded by

  • Agence Nationale de Recherche Contre le SIDA et les Hepatites Virales (ANRS), AC11 HCV Study Group

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (89K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Federico Bolcic, Natalia Laufer, Juan Trinchero, Leandro R. Jones, Jorge Quarleri, A clustering phenomenon among HCV-1a strains among patients coinfected with HIV from Buenos Aires, Argentina, Journal of Medical Virology, 2012, 84, 4
    Direct Link:
  2. 2
    Kazuaki Chayama, Shoichi Takahashi, Joji Toyota, Yoshiyasu Karino, Kenji Ikeda, Hiroki Ishikawa, Hideaki Watanabe, Fiona McPhee, Eric Hughes, Hiromitsu Kumada, Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b–infected null responders, Hepatology, 2012, 55, 3
    Direct Link:
  3. 3
    Hans L. Tillmann, John G. McHutchison, Zakim and Boyer's Hepatology, 2012,

    CrossRef

  4. 4
    Mario Masarone, Marcello Persico, Antiviral therapy: why does it fail in HCV-related chronic hepatitis?, Expert Review of Anti-infective Therapy, 2011, 9, 5, 535

    CrossRef

  5. 5
    M.-W. Welker, C. Welsch, D. Ochs, W. P. Hofmann, E. Herrmann, A. Piiper, R. W. Hartmann, S. Zeuzem, C. Sarrazin, B. Kronenberger, Comparison of Envelope 2 CD81 binding regions in PBMC-derived versus serum-derived hepatitis C virus isolates: higher conservation of CD81 region 2 in PBMC isolates, Journal of Viral Hepatitis, 2011, 18, 3
    Direct Link:
  6. 6
    Erik Alestig, Birgitta Arnholm, Anders Eilard, Martin Lagging, Staffan Nilsson, Gunnar Norkrans, Thomas Wahlberg, Rune Wejstål, Johan Westin, Magnus Lindh, Core mutations, IL28B polymorphisms and response to peginterferon/ribavirin treatment in Swedish patients with hepatitis C virus genotype 1 infection, BMC Infectious Diseases, 2011, 11, 1, 124

    CrossRef

  7. 7
    Dmitry Gryadunov, Ekaterina Dementieva, Vladimir Mikhailovich, Tatiana Nasedkina, Alla Rubina, Elena Savvateeva, Eugeny Fesenko, Alexander Chudinov, Danila Zimenkov, Alexander Kolchinsky, Alexander Zasedatelev, Gel-based microarrays in clinical diagnostics in Russia, Expert Review of Molecular Diagnostics, 2011, 11, 8, 839

    CrossRef

  8. 8
    Rita Almeida Calado, Maria Raquel Rocha, Ricardo Parreira, João Piedade, Teresa Venenno, Aida Esteves, Hepatitis C virus subtypes circulating among intravenous drug users in Lisbon, Portugal, Journal of Medical Virology, 2011, 83, 4
    Direct Link:
  9. 9
    F. Nicot, L. Alric, K. Barange, S. Métivier, J.M. Dramard, J.M. Combis, B. Castan, J.J. Meurisse, J.L. Payen, D. Garipuy, H. Desmorat, J.M. Peron, S. Thebault, T. Morin, C. Renou, P. Barel, B. Guerin, Y. Imbert, S. Sire, K. Sauné, E. Chatelut, J. Izopet, Influence of HCV genotype 1 subtypes on the virus response to PEG interferon alpha-2a plus ribavirin therapy, Journal of Medical Virology, 2011, 83, 3
    Direct Link:
  10. 10
    Aarthi Chary, Mark Holodniy, Interferon combination therapy for HIV/hepatitis C virus coinfection, Immunotherapy, 2011, 3, 9, 1087

    CrossRef

  11. 11
    P Ljungman, A Locasciulli, V G de Soria, A N Békássy, L Brinch, I Espigado, A Ferrant, I M Franklin, J O'Riordan, M Rovira, P Shaw, H Einsele, Long-term follow-up of HCV-infected hematopoietic SCT patients and effects of antiviral therapy, Bone Marrow Transplantation, 2011,

    CrossRef

  12. 12
    Marco Ciotti, Fabbio Marcuccilli, Tania Guenci, Muhammed Babakir-Mina, Federico Chiodo, Mose’ Favarato, Carlo Federico Perno, A multicenter evaluation of the Abbott RealTime HCV Genotype II assay, Journal of Virological Methods, 2010, 167, 2, 205

    CrossRef

  13. 13
    L. Milazzo, I. Caramma, C. Mazzali, M. Cesari, M. Olivetti, M. Galli, S. Antinori, Fluvastatin as an adjuvant to pegylated interferon and ribavirin in HIV/hepatitis C virus genotype 1 co-infected patients: an open-label randomized controlled study, Journal of Antimicrobial Chemotherapy, 2010, 65, 4, 735

    CrossRef

  14. 14
    R. Todd Frederick, Hepatitis C Assays: The Pitfalls of Polymerase Chain Reaction and Genotyping, Current Hepatitis Reports, 2010, 9, 1, 9

    CrossRef

Get PDF (89K)